Ambrx
Mysore Ramprasad (Ram) has a wealth of experience in pharmaceutical and analytical development, having worked in various leadership roles at companies such as Ambrx, aTyr Pharma, CMC Biologics, Halozyme Therapeutics, Pfizer, Favrille, and SkyePharma. In these roles, Ram oversaw the development of various biologics and therapeutics, led teams, and contributed to the successful progression of multiple projects from preclinical stages to regulatory submissions. Mysore holds a Ph.D. in Molecular Biophysics from the Indian Institute of Science and has a background in research and academia from their time at UC San Diego and the University of Alabama at Birmingham.
This person is not in the org chart
This person is not in any teams
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.